Atlas Trials

Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

Clinical trial NCT01709032 · COMPLETED

Trial details

NCT number
NCT01709032
Sponsor
Children's Hospital of Philadelphia
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Thalassemia Major With Severe Transfusional Iron Overload
Start date
2012-09-01
Primary completion
2015-08-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.